The performance from year to year

Litigation battle over a water utility business

Our client, a utilities holding company and a regional government entered into a cooperation agreement on the development of water utility services in the region. The control over the water utilities network was transferred to our client.

Access to LTE network on market conditions

The client and the state-controlled operator have reached a preliminary agreement, whereby the parties intended to conclude the main contract allowing the state-controlled operator access to the client’s LTE network.

Auto group successfully escaped bankruptcy

A Russian auto group asked us for assistance. Its unappealing financial state was aggravated by the prospect of a significant increase in past-due debt. A major bank submitted the claim for collecting the loans totaling over 9.5 billion Rubles.

Dispute with Largest Developer Regarding Payments for Interconnection Services

Our client, a leading private operator in housing and communal services, requested our assistance in a dispute with their region’s largest developer regarding recovery of connection fee.

The court recognized the investor’s claim for 400 million rubles to the bank without any payment documents

We were approached by an investor of a liquidated bank regarding a 400 million ruble deposit. As the bank did not have any records of the deposit, the bankruptcy manager has refused to include the investor’s claim onto the list of creditors.

Amicable agreement over a 469 million Ruble leasing dispute

We were approached by a leasing company, which was in conflict with an investment corporation. The investment corporation and the client entered into an equipment leasing agreement, exceeding 800 million Rubles.

A Russian company vindicated its rights to manufacture of a generic drug

Developer of the original medical drug wished to prevent a Russian company from selling a generic drug. According to the developer, our client had violated the rights related to information about preclinical and clinical testing of the original drug and thus had no right to market the generic drug.

The company defend itself against the illegal claim for the debt recovery for goods with the signs of counterfeit

One of the leading pharmaceutical companies in Russia asked us for assistance in the dispute regarding the recovery of funds from it and penalty for supplied medicinal products.

Dispute regarding the illegal use of a patent on a medicinal product

We were asked by a large pharmaceutical company for assistance in a dispute regarding the illegal use of its patent in the manufacture of medicinal products of another manufacturer.

Мы используем cookies для сбора обезличенных персональных данных. Они помогают анализировать трафик. Оставаясь на сайте, вы соглашаетесь на сбор таких данных. Политика обработки персональных данных